Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the P2X7 receptor: a comparative analysis of conventional methods and AlphaFold.

Frontiers in pharmacology·2026
Same author

Modulation of Patient-Derived Tumor Organoids by SARS-CoV-2 Variants Across Cancer Types: A Study Combining Morphology, Inflammation, and Whole-Exome Profiling.

International journal of molecular sciences·2026
Same author

Light, Dyes, and Action: Photodynamic Inactivation of <i>Leishmania amazonensis</i> Using Methylene Blue, New Methylene Blue, and Novel Ruthenium-Based Derivatives.

Biology·2025
Same author

Preparing for Practice: A Comparative Analysis of Anesthesiology Residency Competencies in Brazil, Spain, and the United Kingdom.

Journal of medical education and curricular development·2025
Same author

Joannesia princeps Vell. inhibits purinergic P2Y receptors and presents antinociceptive and anti-inflammatory effects.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Anesthesiology competencies in undergraduate medical education: a comparative study of curriculum frameworks in Brazil, Spain, and the United Kingdom.

BMC medical education·2025

Related Experiment Video

Updated: Jun 25, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

A Hybrid Approach Combining Shape-Based and Docking Methods to Identify Novel Potential P2X7 Antagonists from Natural

Natiele Carla da Silva Ferreira1, Lucas Gasparello Viviani2, Lauro Miranda Lima1

  • 1Laboratory of Cellular Communication, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.

Pharmaceuticals (Basel, Switzerland)
|May 25, 2024
PubMed
Summary
This summary is machine-generated.

This study developed a new virtual screening method to find natural compounds that could block the P2X7 receptor, a target for inflammatory and neurodegenerative diseases. The approach successfully identified eight potential P2X7 receptor antagonists from natural product databases.

Keywords:
P2X7 receptorantagonistsnatural productsshape-based modelvirtual screening

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

12.8K

Related Experiment Videos

Last Updated: Jun 25, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

12.8K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Drug Discovery

Background:

  • The P2X7 receptor is a key mediator of pro-inflammatory responses and is linked to various diseases.
  • Existing P2X7 receptor antagonists lack clinical approval, highlighting the need for novel therapeutic agents.
  • Natural products offer a rich source for discovering new drug scaffolds.

Purpose of the Study:

  • To develop an improved virtual screening methodology for identifying novel P2X7 receptor antagonists from natural product databases.
  • To combine shape-based screening and molecular docking to enhance the accuracy of virtual screening.
  • To identify potential P2X7 receptor antagonists with drug-like properties and novel chemical structures.

Main Methods:

  • Shape-based virtual screening was performed using JNJ-47965567 as a reference against two natural product databases (MEGx and NATx).
  • Compounds were filtered for drug-like properties based on established criteria.
  • Molecular docking using GOLD and DockThor was employed to assess binding affinity to the P2X7 allosteric site.
  • Visual inspection of docking poses identified key interactions with P2X7 binding pocket residues.

Main Results:

  • The combined shape-based and docking approach successfully filtered large natural product libraries.
  • Eight compounds, four from MEGx and four from NATx, were selected as potential P2X7 receptor antagonists.
  • The identified compounds possess drug-like properties and distinct chemical structures compared to known antagonists.
  • Predicted interactions with critical P2X7 allosteric binding pocket residues (e.g., F88, Y298, I310) were observed.

Conclusions:

  • The proposed virtual screening methodology effectively identifies novel P2X7 receptor antagonist candidates from natural products.
  • This approach offers a valuable strategy for discovering potential inhibitors/antagonists for other biological targets.
  • The identified natural compounds represent promising leads for further development in treating inflammatory and neurodegenerative conditions.